Company News, Patents

Dermala Expands Patent Roster with Latest Eczema Treatment Technology

Technology uses novel derivatives of postbiotic metabolites derived from C. acnes in the human skin microbiome to inhibit S. aureus.

Author Image

By: Christine Esposito

Editor-in-Chief

Consumer dermatology company Dermala, Inc. has been awarded a US patent (No. 11,364,214) for compositions and method for treating eczema. This is the fourth patent in the San Diego-based company’s expanding intellectual property (IP) portfolio. This latest patent covers using the human microbiome to treat and prevent atopic dermatitis (eczema) without using steroids or immunomodulators associated with side effects. Dermala's patented technology uses novel derivatives of postbiotic metabo...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters